Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Process for making diethyl ether from acetic acid
Focus detection device and imaging apparatus having the same
Dynamic lookup service in a distributed system
Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
Systems and methods for automated institutional processing of payments
Neurophysiological central auditory processing evaluation system and method
Light-emitting device
  Randomly Featured Patents
System for determining the current-voltage characteristics of a photovoltaic array
Melt-processable block copolyesterimide and method for manufacturing it
Bicycle exercise stand
Apparatus for measuring oxygen consumption and the exchange of other breathing gases
Low density mist collector pad
Counter weighted lifting beam
Pyrrolopyridinylpyrimidin-2-ylamine derivatives
Communication switching method in communication system
Look-ahead refresh for an integrated circuit memory
Optomicrowave integrated circuit